This ASX cannabis share could soon be taken over

The Creso Pharma Ltd (ASX:CPH) share price remains suspended following the release of a takeover update…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Creso Pharma Ltd (ASX: CPH) share price won't be going anywhere today and will remain suspended following the release of the cannabis company's takeover update.

What has happened?

In June of this year Canadian cannabis company PharmaCielo made an offer to acquire Creso Pharma in an all scrip deal that originally valued it at $122 million.

In August the independent expert's report from BDO Corporate Finance concluded that the share scheme was not fair but reasonable and was therefore in the best interest of Creso Pharma shareholders.

However, on September 16 BDO issued a letter to the company withdrawing its independent expert's report. That letter noted that, as per its requirements, BDO had been monitoring market circumstances that drive valuation assumptions, and consequential opinions.

It noted that the then prevailing market price of PharmaCielo shares on TSX-V had declined significantly below the valuation range outlined in the report, to the point where BDO no longer considered the schemes to be in the best interests of Creso Pharma's securityholders.

Since then, though, the PharmaCielo share price has pushed higher following a series of positive announcements pertaining to both businesses. This led to BDO issuing a new independent expert's report concluding that the schemes are in the best interest of Creso Pharma securityholders once again, in the absence of a superior offer.

What now?

This saga still has a few more hurdles to clear before it comes to an end.

The scheme booklet has been updated and has been resubmitted to ASIC for its continuing review. Subject to the satisfactory conclusion of ASIC's review, the company intends to proceed with its first court hearing on October 2.

Dr Miri Haperin Wernli, Creso Pharma CEO and co-founder said: "We are very pleased to have received the additional certainty provided by the positive opinion of the Independent Expert. The Creso Pharma board remains committed to the Schemes and Creso Pharma is excited to be progressing the Schemes towards completion which is now likely to occur in mid to late November 2019."

Elsewhere in the industry today, the Althea Group Holdings Ltd (ASX: AGH) share price has pushed 2% higher and the Cann Global Ltd (ASX: CGB) share price is down 3%.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Mergers & Acquisitions

A man sits in a chair hunched over a laptop and covered head to toe in frozen icicles to represent Envirosuite's trading halt
Mergers & Acquisitions

APM share price placed on ice as $1.8 billion deal goes dud

It's all question marks and raised eyebrows for shareholders of this ASX company today.

Read more »

Young man sitting at a table in front of a row of pokie machines staring intently at a laptop. looking at the Crown Resorts share price
Mergers & Acquisitions

Could Star Entertainment shares be next in line to catch a takeover bid?

Star shares have been battered, but could a buyout be coming?

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Bank Shares

Own CBA shares? Here's the tech stock the banking giant just invested in

CBA has made an interesting investment. Here's what you need to know.

Read more »

Man pointing at a blue rising share price graph.
Mergers & Acquisitions

Guess which ASX 300 stock is rocketing 10% on a $985 million cash bid!

Investors are piling into the ASX 300 stock on the back of a $985 million cash takeover bid.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Mergers & Acquisitions

Guess which ASX blue-chip share is throwing $202 million at another acquisition

This Aussie healthcare company is growing its presence in Switzerland.

Read more »

A man stands with his arms crossed in an X shape.
Mergers & Acquisitions

Boral share price falls after rejecting Seven Group takeover

The offer 'undervalues' Boral according to its committee.

Read more »

Miner looking at a tablet.
Materials Shares

Mineral Resources share price marching higher on new lithium project acquisition

ASX 200 investors are bidding up the Mineral Resources share price on Monday.

Read more »

A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
Technology Shares

Appen shares plunges 17% after takeover collapse

Well that didn't take long...

Read more »